Celator Pharmaceuticals Inc 4
4 · Celator Pharmaceuticals Inc · Filed May 28, 2015
Insider Transaction Report
Form 4
Mayer Lawrence David
President and Head of Research
Transactions
- Exercise/Conversion
Common Stock
2015-05-14$2.25/sh+55,000$123,750→ 71,594 total - Exercise/Conversion
Stock Option, Right to Buy
2015-05-14−55,000→ 7,829 totalExercise: $2.25Exp: 2015-05-24→ Common Stock (55,000 underlying)
Holdings
- 3,631(indirect: By Trust)
Common Stock
- 7,468(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The option was fully exercisable. Options to purchase 7,829 shares expired on 5/24/15.